MX9705609A - Compuesto de bismuto. - Google Patents

Compuesto de bismuto.

Info

Publication number
MX9705609A
MX9705609A MX9705609A MX9705609A MX9705609A MX 9705609 A MX9705609 A MX 9705609A MX 9705609 A MX9705609 A MX 9705609A MX 9705609 A MX9705609 A MX 9705609A MX 9705609 A MX9705609 A MX 9705609A
Authority
MX
Mexico
Prior art keywords
bismuth compounds
bismuth
agents
compounds
contrast
Prior art date
Application number
MX9705609A
Other languages
English (en)
Other versions
MXPA97005609A (es
Inventor
Jo Klaveness
Arne Berg
Torsten Almen
Klaes Golman
Michael Droege
Shi-Bao Yu
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9501560.8A external-priority patent/GB9501560D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of MX9705609A publication Critical patent/MX9705609A/es
Publication of MXPA97005609A publication Critical patent/MXPA97005609A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/94—Bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

El uso en la formacion de imágenes para diagnostico, en particular rayos-X, MRI, ultrasonido y centegrafía, de agentes de contraste que constan de grupos bismuto y/o compuestos de bismuto orgánicos, y un medio de contraste que contiene tales compuestos de bismuto. Los compuestos de bismuto son también utiles en terapia, en particular como agentes antimicrobiales y como agentes antiulcerantes. Nuevos compuestos de bismuto son también revelados.
MXPA/A/1997/005609A 1995-01-26 1997-07-24 Compuesto de bismuto MXPA97005609A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9501560.8A GB9501560D0 (en) 1995-01-26 1995-01-26 Contrast agents
GB9501560.8 1995-01-26
US08486225 1995-06-07
US08/486,225 US5817289A (en) 1995-01-26 1995-06-07 Non-cluster type bismuth compounds
PCT/GB1996/000183 WO1996022994A1 (en) 1995-01-26 1996-01-26 Bismuth compounds

Publications (2)

Publication Number Publication Date
MX9705609A true MX9705609A (es) 1997-10-31
MXPA97005609A MXPA97005609A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
FI973117A (fi) 1997-09-25
DE69620582D1 (de) 2002-05-16
US6117412A (en) 2000-09-12
DE69620582T2 (de) 2002-11-07
CN1177357A (zh) 1998-03-25
FI973117A0 (fi) 1997-07-25
EP0805815B1 (en) 2002-04-10
HUP9900428A2 (hu) 1999-06-28
AU4493796A (en) 1996-08-14
CA2211873A1 (en) 1996-08-01
JPH10512877A (ja) 1998-12-08
EP0805815A1 (en) 1997-11-12
NO973459D0 (no) 1997-07-25
WO1996022994A1 (en) 1996-08-01
NO973459L (no) 1997-09-25

Similar Documents

Publication Publication Date Title
IL150258A0 (en) Cascade polymer complexes
NO973459L (no) Vismut-forbindelser
AU5864296A (en) Diagnostic imaging x-ray contrast agents
AU4764396A (en) Calcium/oxyanion-containing particles for use in medical diagnostic imaging
GB9203037D0 (en) Contrast agents
CA2107466A1 (en) Low density microspheres and their use as contrast agents for computed tomography
EP0487110A3 (en) Computer-aided diagnosis system for medical use
IE892685L (en) Preparation comprising cavitate- or clathrate-forming¹host/guest complexes as contrast agent
AU4215185A (en) Use of ferromagnetic particles in contrast agents for nmr imaging and contrast agents
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
AU6632194A (en) Treated calcium/oxyanion-containing particles for medical diagnostic imaging
GB2298368B (en) Medical needle assembly for use in ultrasound imaging
GB9524934D0 (en) Treatment and diagnosis of infections due to helicobacter pylori
EP0472494A3 (en) Anti-pathogenic biocontrol agents, genes encoding antibiotics synthesis and the use of said antibiotics
HK1068251A1 (en) Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
AU1214995A (en) Cdna probe for breast cancer diagnosis and treatment
GR3035126T3 (en) Substituted 2-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them
AU2823795A (en) 2,4,6-triiodo-5-substituted-amino-isophthalate esters useful as x-ray contrast agents for medical diagnostic imaging
AU3436295A (en) Diagnostic imaging agent
IL159479A0 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
AU8144894A (en) Biphenyl iodinated derivatives and their diagnostic use
AU5103096A (en) Use of ferrites for determining the perfusion of human tissue by m.r. diagnosis
EP0666745A4 (en) METHODS OF DIAGNOSING AND TREATING PARKINSON'S DISEASE.
AU2784695A (en) Complex compounds for diagnosis of vascular diseases